PLRX

PLIANT THERAPEUTICS INC

PLRX·729139105·US·Common Stock·Healthcare - Biotechnology-13D/G

PLRX (PLIANT THERAPEUTICS INC) is held by 48 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.8M), TWO SIGMA INVESTMENTS, LP ($2.6M), CITADEL ADVISORS LLC ($2.4M). Net institutional sentiment: Bearish.

48
Holders
(1 Elite)
$21.3M
Total Value
25% (40)
Consensus
10 buying - 30 selling
13F: Insider & Congress: Updated regularly
PLRX

Smart Money Verdict

View all
Loading verdict
Held by 48 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jan 22, 2026 · Activists Aug 14, 2026 · Congress none

ActivistKenneth GriffinKenneth Griffin3.5%Aug 14, 2026
ActivistADADAR1 Capital Management, LLC8.9%Aug 14, 2026
ActivistWoodline Partners LPWoodline Partners LP3.3%Feb 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.4M(+4.2%)$2.8M0.0%-6.87%
27
Increased
2.3M(+0.4%)$2.6M0.0%-35.65%
26
Decreased
2.1M(-33.6%)$2.4M0.0%-6.99%
0
Increased
2M(+10.6%)$2.3M0.0%-22.30%
29
Decreased
1.3M(-22.2%)$1.5M0.0%-38.30%
0
Increased
1.2M(+5.0%)$1.3M0.0%-90.23%
18
Decreased
835,124(-16.1%)$952,0410.0%-9.91%
0
Decreased
681,647(-20.9%)$783,8940.0%-39.85%
0
Decreased
643,120(-10.5%)$733,1570.0%-14.84%
0
Increased
578,577(+38.7%)$659,9540.0%-91.60%
22
Decreased
571,760(-46.0%)$651,8060.0%-73.50%
0
Decreased
559,447(-52.6%)$637,7700.0%-7.20%
0
Increased
536,081(+3.6%)$611,1320.0%-5.78%
25
Decreased
440,844(-12.0%)$502,5620.0%-19.12%
0
Increased
341,751(+0.7%)$389,5960.0%-7.15%
24
Decreased
298,976(-40.9%)$340,8330.0%-65.71%
0
Unchanged
297,291$338,9090.0%-19.04%
0
Unchanged
253,418$288,8970.0%-93.44%
0
Decreased
208,585(-65.0%)$237,7870.0%-77.96%
0
Decreased
153,712(-0.1%)$175,2320.0%-7.20%
0

Showing 1-20 of 55

1 / 3
PLRXPLRXPLIANT THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used